Clinical Trial Update: A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose study of AGMB-129 in healthy participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AGMB-129

Snippet

Sponsor: Agomab Spain S.L.U. | Conditions: Fibrostenotic Crohn's Disease | Phase 1 | Status: COMPLETED